Chemotherapy News and Research

Latest Chemotherapy News and Research

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

Oncotarget published "Eltrombopag and its iron chelating properties in pediatric acute myeloid leukemia" which reported that the standard treatment for pediatric AML currently consists in a combination of cytarabine and antracycline.

9 Aug 2021

MRI texture features can predict response to neoadjuvant chemotherapy in patients with breast cancer

Oncotarget published "MRI texture features from tumor core and margin in the prediction of response to neoadjuvant chemotherapy in patients with locally advanced breast cancer" which reported that the authors investigated whether pre-treatment T2-weighted magnetic resonance imaging can be used to predict response to neoadjuvant chemotherapy in breast cancer.

6 Aug 2021

Scientists use AI to identify new biomarkers for breast cancer

Scientists at Case Western Reserve University have used Artificial Intelligence (AI) to identify new biomarkers for breast cancer that can predict whether the cancer will return after treatment - and which can be identified from routinely acquired tissue biopsy samples of early-stage breast cancer.

6 Aug 2021

Using circulating tumor DNA to detect urothelial cancer relapse could help improve treatment

Using circulating tumor DNA to identify patients at risk of urothelial cancer relapse after surgical resection could help improve post-surgery treatment.

6 Aug 2021

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Shuo Ma, MD, '00 PhD, associate professor of Medicine in the Division of Hematology and Oncology, was co-first author of the clinical trial published in Blood.

5 Aug 2021

Experimental drug combination extends survival in mice with lung cancer, study finds

A combination of experimental drugs increased the attack of immune cells on non-small cell lung cancer (NSCLC) to extend survival in mice, a new study found.

5 Aug 2021

Research explores how cancer cells develop resistance to chemotherapy

Cancer cells sometimes develop resistance to the cytotoxic drugs used in chemotherapy. Figuring out why the treatment isn't working and why it may even defeat its own purpose is therefore important to understand.

5 Aug 2021

Study investigates the role of eIF4A3 protein in the growth of cancer cells

For a cell to grow and divide, it needs to produce new proteins. This also applies to cancer cells. In a new study published today in Science Advances, researchers at Karolinska Institutet in Sweden have investigated the protein eIF4A3 and its role in the growth of cancer cells.

4 Aug 2021

Large catheters, small veins raise thrombosis risk for cancer patients

A world-first study led by the University of South Australia has found that cancer patients receiving chemotherapy intravenously have more than double the risk of developing a blood clot or thrombosis if the vein is too small and the catheter occupies more than 45 per cent of the vein.

4 Aug 2021

Next-Generation Sequencing and the Diagnosis of Disease

In this interview, Professor John Rossen talks about next-generation sequencing and it's implications for the diagnosis of disease.

From Tecan 4 Aug 2021

BioCurate’s new “Proof of Concept” funding to help accelerate research into targeted cancer therapies

The first award under BioCurate’s new “Proof of Concept” fund has been granted to the Monash Biomedicine Discovery Institute.

4 Aug 2021

Discovery may enable the development of new therapies to kill aggressive cancer cells

Vanderbilt faculty and researchers are looking for the "Achilles' heel" of the cancer cells that survive initial chemotherapy.

3 Aug 2021

COVID-19 lockdowns had minimal impact on medical treatments for Australian cancer patients

Australian cancer patients kept up their pharmaceutical treatments during last year's COVID-19 lockdowns, a big data study from UNSW Sydney shows.

3 Aug 2021

Anti-parasitic drug prevents pancreatic cancer's initiation, progression and metastasis in mice

As the third-most lethal cancer in the United States, with only a 1% five-year survival rate for people with its most aggressive form, pancreatic cancer has long been a target of researchers who search for ways to slow or stop its growth and spread.

3 Aug 2021

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

The Republic of Belarus Ministry of Health has approved expanding the ongoing clinical trial of CureLab Oncology's Elenagen, an experimental DNA therapy, to include two new arms: 1) hormone-resistant breast cancer; and 2) hormone-resistant metastatic prostate cancer.

3 Aug 2021

New discovery could pave the way towards therapeutic treatments for many cancers

Princess Margaret Cancer Centre researchers have made new findings which provide a broader understanding of how dormant hematopoietic stem cells are activated and could pave the way towards therapeutic treatments for a number of cancers.

2 Aug 2021

Study finds racial and ethnic disparities in post-operative breast cancer surgery outcomes

Breast cancer is the most commonly diagnosed cancer among American women and surgery is a primary treatment for these women. Among women receiving surgery, up to 13% will have a post-operative visit to an emergency department, according to recent research.

2 Aug 2021

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

The Centers for Disease Control and Prevention (CDC) issued a letter detailing a case of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an immunocompromised patient who did not respond well to monoclonal antibody treatment. The resistance to treatment stemmed from an escape mutation on the spike protein known as Q4923R.

2 Aug 2021

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Researchers at Wake Forest School of Medicine have shown that a targeted therapy using non-thermal radio waves is safe to use in the treatment of hepatocellular carcinoma (HCC), the most common type of liver cancer.

30 Jul 2021

Study: All GA-binding proteins have the highest expression levels in secondary glioblastomas

Oncotarget published "TERT and its binding protein: overexpression of GABPA/B in high grade gliomas" which reported that all GA-binding proteins progress through the glioma grades and have the highest expression levels in secondary glioblastomas.

28 Jul 2021

Chemotherapy News and Research

Latest Chemotherapy News and Research

Iron chelating properties of eltrombopag in pediatric acute myeloid leukemia

MRI texture features can predict response to neoadjuvant chemotherapy in patients with breast cancer

Scientists use AI to identify new biomarkers for breast cancer

Using circulating tumor DNA to detect urothelial cancer relapse could help improve treatment

Combination therapy improves outcomes for relapsed chronic lymphocytic leukemia

Experimental drug combination extends survival in mice with lung cancer, study finds

Research explores how cancer cells develop resistance to chemotherapy

Study investigates the role of eIF4A3 protein in the growth of cancer cells

Large catheters, small veins raise thrombosis risk for cancer patients

Next-Generation Sequencing and the Diagnosis of Disease

BioCurate’s new “Proof of Concept” funding to help accelerate research into targeted cancer therapies

Discovery may enable the development of new therapies to kill aggressive cancer cells

COVID-19 lockdowns had minimal impact on medical treatments for Australian cancer patients

Anti-parasitic drug prevents pancreatic cancer's initiation, progression and metastasis in mice

Hormone-resistant prostate, breast cancers added to clinical trial of experimental DNA therapy

New discovery could pave the way towards therapeutic treatments for many cancers

Study finds racial and ethnic disparities in post-operative breast cancer surgery outcomes

SARS-CoV-2 Q493R protein mutation shows resistance to monoclonal antibodies

Study shows safety and efficacy of radio-wave therapy for liver cancer patients

Study: All GA-binding proteins have the highest expression levels in secondary glioblastomas

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in